Catalyst Pharmaceuticals (CN2.F) Q2 2026 Earnings

11MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.29
0.33
0.38
0.42

Details

Expected EPS
0.40327025
Actual EPS
0.424495
Surprise EPS
0.02
Surprise Percent
+5.26%

Description

Catalyst Pharmaceuticals (CN2.F) has reported earnings of 0.424495 per share for Q2 2026.

0 Comments

Share your thoughts